
Sam Fazeli
Director of Research, Global Industries at Bloomberg Línea
Director of Research, Global Industries, Bloomberg Intelligence. Views my own. Not recommending buy/hold/sell.
Articles
-
Sep 8, 2022 |
bloomberg.com | Lisa Jarvis |Sam Fazeli
-
Sep 8, 2022 |
washingtonpost.com | Lisa Jarvis |Sam Fazeli
-
Aug 25, 2022 |
postguam.com | Therese Raphael |Sam Fazeli
-
Aug 24, 2022 |
fredericknewspost.com | Therese Raphael |Sam Fazeli
-
Aug 22, 2022 |
timeslive.co.za | Therese Raphael |Sam Fazeli
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 4K
- DMs Open
- No

$GURBF US $ABBV $NVO $MTSR $VKTX $GPCR $ZLDPF $AMGN $SNY $RHHBY $PRTA $ANVS $LLY $ALC $AZN Listen to Liberation Day for Pharma; Obesity & Parkinson: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud https://t.co/e17Q00dXhP

$JNJ $CGON $AURA $TARA $BIIB $IONS $PTCT $NVS $NOV $GPCR $LLY $VKTX $IVBXF Listen to Washington Updates; Obesity Pipeline; MDA/EAU Data: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud https://t.co/LJvKizGQJe

The problem is whether Europe is able to receive them and, more importantly, fund them. Also, the VC funding environment and risk appetite in the US is orders of magnitude higher than in Europe (or Canada)

Source: https://t.co/OELQ0lPdgP